| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| G5D8R7 | Cytochrome c oxidase subunit 1; EC 1.9.3.1; | COX1; | NULL | 513 | human |
| B4DIB7 | cDNA FLJ50965, highly similar to Beta-neoendorphin-dynorphin; cDNA, FLJ78975, highly similar to Beta-neoendorphin-dynorphin; | NULL | NULL | 109 | human |
| Q5T114 | Chromosome 9 open reading frame 156, isoform CRA_b; Nef-associated protein 1; | C9orf156; | XP_005252105.1;XP_005252106.1;XP_005252107.1; | 295 | human |
| H0Y2X1 | Chromosome 17 open reading frame 62, isoform CRA_c; Uncharacterized protein C17orf62; | C17orf62; | NULL | 63 | human |
| B7TMW4 | Cytochrome c oxidase subunit 3; | COX3; | NULL | 260 | human |
| D2IYL0 | Psoriasis susceptibility 1 candidate 1; SEEK1; | PSORS1C1; | NP_054787.2; | 152 | human |
| Q86SI2 | Full-length cDNA 5-PRIME end of clone CS0DF033YP12 of Fetal brain of Homo sapiens; human; cDNA FLJ59904; Full-length cDNA clone CS0DI080YG21 of Placenta of Homo sapiens (human); | NULL | NULL | 138 | human |
| B4E3Q4 | Adenosine deaminase CECR1; cDNA FLJ58672, highly similar to Cat eye syndrome critical region protein 1; | CECR1; | NP_001269156.1;NP_001269157.1;NP_803124.1; | 469 | human |
| A0A024R1M5 | Zinc finger protein 278, isoform CRA_c; | ZNF278; | NULL | 687 | human |
| B5A964 | Fibroblast growth factor receptor 4; Soluble FGFR4 variant 1; | FGFR4; | NULL | 72 | human |
| U3M9P0 | Cytochrome c oxidase subunit 1; EC 1.9.3.1; Fragment; | COI; | NULL | 228 | human |
| A0A024R0H0 | Seryl-tRNA synthetase 2, isoform CRA_c; | SARS2; | NULL | 328 | human |
| B8ZZ56 | AN1-type zinc finger protein 2B; | ZFAND2B; | NULL | 145 | human |
| Q2Q9H2 | Glucose-6-phosphate 1-dehydrogenase; EC 1.1.1.49; Fragment; | G6PD; | NULL | 475 | human |
| D6R933 | Ubiquitin-conjugating enzyme E2 D3; | UBE2D3; | NULL | 48 | human |
| J3KSF0 | 5'(3')-deoxyribonucleotidase, cytosolic type; | NT5C; | NULL | 39 | human |
| A6YZY0 | Cytochrome c oxidase subunit 3; | COX3; | NULL | 260 | human |
| B7TCM5 | ATP synthase protein 8; | ATP8; | NULL | 68 | human |
| G9LC48 | ATP synthase protein 8; | ATP8; | NULL | 68 | human |
| Q50KP5 | Taste receptor type 2; Fragment; | Hosa(Japanese)-T2R14; Hosa(Adygei)-T2R14 Hosa(Biaka)-T2R14; | NULL | 292 | human |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |